Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 145.80183.28-128.1825.75320.55

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 145.80 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024145.80
Mar2023183.28
Mar2022-128.18
Mar202125.75
Mar2020320.55

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 145.8
-20.45
Mar2023 183.28
Positive
Mar2022 -128.18
Negative
Mar2021 25.75
-91.97
Mar2020 320.55 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹125.7 Cr 1.8% -25.3% -50.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,550.5 Cr -7.2% -13.9% 83.6% Stock Analytics
KIRI INDUSTRIES ₹3,253.7 Cr -9.3% 2.8% 52.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,302.0 Cr -6.7% -1.6% 5.7% Stock Analytics
BODAL CHEMICALS ₹823.3 Cr 2.2% 3.5% -16% Stock Analytics
BHAGERIA INDUSTRIES ₹784.1 Cr -12.2% -0.8% 8.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.8%

-25.3%

-50.4%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses